Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTiton Regulatory News (TON)

Share Price Information for Titon (TON)

Share Price is delayed by 15 minutes
Get Live Data
80.00    0.00 (0.00%)
Bid:
75.00
Ask:
85.00
Spread: 10.00 (13.333%)
Market Cap: £9.00m
TON Live PriceLast checked at - London Stock Exchange

Intraday Titon Share Chart

Trading Update

29 Nov 2022 07:00

RNS Number : 8469H
Titon Holdings PLC
29 November 2022
 

LEI: 213800ZHXS8G27RM1D97

 

This announcement contains inside information

29 November 2022

 

Titon Holdings Plc

 

Trading Update

 

Titon Holdings Plc ("Titon", the "Group" or the "Company") provides the following update on the Group's expected results for the year to 30 September 2022 ("FY21/22") and on the outlook for the year to 30 September 2023 ("FY22/23").

FY21/22 results

Trading in UK and Europe through to the end of the FY21/22 period continued in line with the Group's expectations following its update on 22 July 2022, as the Group managed the inflationary environment, the ERP system implementation and the supply chain challenges that were present in FY21/22.

However, as a result of the previously reported weak housing market and shift in market demand to mechanical ventilation products from natural ventilation in the South Korean market, Titon's South Korean business has reported to the Group a further decline in results for FY21/22. As a result, Titon now expects that the Group's overall underlying loss before tax and exceptional items will be moderately larger than previously anticipated.

The Group's financial results for FY21/22 remain subject to the completion of the Group's audit. The Group expects that its final audited results for FY21/22 will be published in January 2023.

Current trading and outlook

Trading in the first two months of the Group's current financial year to 30 September 2023 ("FY22/23") has been in line with our expectations in the UK and Europe.

While supply chain shortages have eased, the Group continues to manage inflationary margin erosion through customer price increases, material cost savings and internal efficiencies. The Group has increased the output of Ventilation Systems products as supply shortages have eased and we have invested to increase capacity for our Hardware products to satisfy the increased demand resulting from the Building Regulation changes in June 2022.

In the UK and Europe, we currently expect to report a loss before tax and exceptional items in H1 FY22/23, but we expect to return to profitability in H2 FY22/23. Whilst FY22/23 results overall will be somewhat lower than our previous expectations, we expect FY22/23 will show a full year improvement in performance when compared to our expected FY21/22 results.

Having filled key management vacancies, we now have a strong and experienced leadership team in place whose focus is to improve business performance. In addition, we have an ongoing strong order book with our customers.

Titon Korea is expected to remain loss-making in FY22/23 due to the challenging market conditions, as the Group has yet to see significant sales of mechanical ventilation products launched in response to the shift in demand in that market.

Strong balance sheet

The Group continues to maintain a healthy balance sheet with no indebtedness. Group cash at 30 September 2022 was £1.7m. Following the investment in the Group's inventory holding during FY21/22 in order to mitigate the previous supply chain issues, a strategic focus in FY22/23 will be to reduce our inventory holding to normalised levels, to match order book demand and maximise our liquidity and overall working capital positions.

 

Alexandra French, CEO, commented:

"After a challenging year, we are comforted that the UK and Europe business performed in line with our revised expectations and has had a reasonable start to the new financial year. However, we are obviously disappointed to report that overall, the Group's trading performance for the FY21/22 full year will be lower than previously indicated due to the poor performance of our Korean subsidiary.

From a UK and European perspective, we now have a strong leadership team in place who have defined a clear vision for the business, and we are confident that this will enable us to deliver stability and ultimately a return to profit in these regions in H2 FY22/23. Titon Korea's return to profitability is now likely to be in the medium term while it develops its position in the mechanical ventilation market and we are therefore evaluating options for streamlining the corporate structure and operations of the Korean business.

We thank all of our customers for their valued business, and we look forward to returning to our strong levels of customer service. We also thank our employees for their continued hard work and commitment during what has been a difficult year. Despite these difficulties we remain confident in our medium-term future, supported by our strong financial position."

 

ENDS

 

For further information please contact:

 

Titon Holdings Plc

Keith Ritchie 

Alexandra French

 

Tel: +44 (0)7748 146834

Tel: +44 (0)7949 409132

 

Shore Capital (Nominated Adviser and Broker)

Daniel Bush

Tom Knibbs

Tel: +44 (0)20 7408 4090

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBKFBQCBDDADB
Date   Source Headline
1st Jun 20267:00 amRNSAcquisition
30th Apr 20267:00 amRNSInterim results
17th Apr 20267:00 amRNSNotice of Interim Results & Investor Presentation
20th Mar 20267:00 amRNSResult of AGM
19th Mar 20267:00 amRNSAGM Trading Update
23rd Feb 20267:00 amRNS2025 Annual Report and Notice of AGM
15th Jan 20267:00 amRNSAnnual Financial Report
2nd Dec 20257:00 amRNSDirector/PDMR Shareholding
24th Nov 20257:00 amRNSHolding(s) in Company
17th Oct 20257:00 amRNSFull Year Trading Update
29th Sep 20252:18 pmRNSHolding(s) in Company
29th Sep 202512:42 pmRNSHolding(s) in Company
14th Jul 20257:00 amRNSHolding(s) in Company
11th Jul 20259:10 amRNSHolding(s) in Company
7th Jul 20259:01 amRNSDirector/PDMR Shareholding
12th May 20257:00 amRNSDirector/PDMR Shareholding
30th Apr 20257:00 amRNSUnaudited Interim Results to 31 March 2025
25th Apr 20257:00 amRNSNotice of Interim Results & Investor Presentation
1st Apr 20257:00 amRNSHolding(s) in Company
25th Mar 20253:10 pmRNSResult of AGM
25th Mar 20257:00 amRNSAGM Trading Update
18th Mar 202512:03 pmRNSDirector/PDMR Shareholdings
3rd Mar 20257:00 amRNS2024 Annual Report and Notice of AGM
23rd Jan 20257:00 amRNSAnnual Financial Report
20th Jan 20257:00 amRNSNotice of Results and Investor Presentation
16th Dec 20247:00 amRNSCompletion of Disposal and Update on FY24 Results
29th Oct 20241:46 pmRNSDirector/PDMR Shareholdings
24th Oct 20247:00 amRNSCommencement of Process to Dispose of Korean Ops
3rd Sep 20247:00 amRNSNon-Executive Board Change
19th Jul 20242:05 pmRNSGrant of options and Director/PDMR Shareholding
11th Jul 20247:00 amRNSTrading Update and Board Change
15th May 20247:00 amRNSInterim Results for six months to 31 March 2024
25th Apr 20247:00 amRNSNotice of Interim Results & Investor Presentation
17th Apr 20242:15 pmRNSNotification of Major Holdings
2nd Apr 20242:43 pmRNSHolding(s) in Company
27th Mar 202411:28 amRNSResult of Annual General Meeting
26th Mar 20247:00 amRNSAGM Trading Update
27th Feb 20245:00 pmRNSDirector/PDMR Shareholding
26th Feb 20243:15 pmRNS2023 Annual Financial Report and Notice of AGM
25th Jan 20247:00 amRNSAnnual Financial Report year ended 30 Sept 2023
19th Jan 20241:07 pmRNSInvestor Presentation via Investor Meet Company
22nd Dec 20237:00 amRNSConfirmation of Board Appointment
5th Dec 20237:00 amRNSNotification of Major Holdings
4th Dec 20237:00 amRNSTrading Update
29th Nov 20237:00 amRNSNon-Executive Director Changes
22nd Nov 20237:00 amRNSAppointment of CEO
6th Oct 20234:00 pmRNSExercise of Options and Total Voting Rights
14th Sep 20233:45 pmRNSHolding(s) in Company
30th Aug 20232:17 pmRNSNotification of Major Holdings
4th Jul 20234:30 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.